www.fdanews.com/articles/123826-lexicon-reports-positive-result-from-phase-ii-study
Lexicon Reports Positive Result From Phase II Study
January 20, 2010
Lexicon Pharmaceuticals Inc. said Wednesday that it obtained positive results from
a recently completed Phase 2 study of its LX4211 drug in patients with type 2 diabetes mellitus.
MarketWatch
MarketWatch